是时候将IGLV3-21R110状态纳入慢性淋巴细胞白血病的预后评估了吗？ - Suppr

Suppr

超能文献

Time to include IGLV3-21R110 status in CLL prognostication?

作者信息

Rosenquist Richard

机构信息

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Blood Adv. 2023 Dec 12;7(23):7382-7383. doi: 10.1182/bloodadvances.2023011243.

DOI:10.1182/bloodadvances.2023011243

PMID:38085552

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10726237/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/102f/10726237/eaef290ef828/BLOODA_ADV-2023-011243-C-gr1.jpg

相似文献

Time to include IGLV3-21R110 status in CLL prognostication?是时候将IGLV3-21R110状态纳入慢性淋巴细胞白血病的预后评估了吗？

Blood Adv. 2023 Dec 12;7(23):7382-7383. doi: 10.1182/bloodadvances.2023011243.

IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.IGLV3-21R110 鉴定出具有中间表观遗传学的侵袭性慢性淋巴细胞白血病生物学亚型。

Blood. 2021 May 27;137(21):2935-2946. doi: 10.1182/blood.2020008311.

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.IGLV3-21R110突变对未经治疗的慢性淋巴细胞白血病患者具有预后价值。

Blood Adv. 2023 Dec 12;7(23):7384-7391. doi: 10.1182/bloodadvances.2023010132.

is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling.是 CLL 的遗传风险因素，通过获得允许自主 BCR 信号转导的单点突变。

Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4320-4327. doi: 10.1073/pnas.1913810117. Epub 2020 Feb 11.

5' Rapid amplification of cDNA ends (5'RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia.5' 快速扩增 cDNA 末端（5'RACE）：一种更简单的分析免疫球蛋白基因的方法，并发现慢性淋巴细胞白血病中轻链的价值。

Leuk Res. 2022 Dec;123:106952. doi: 10.1016/j.leukres.2022.106952. Epub 2022 Sep 16.

Chronic lymphocytic leukemia with mutated IgVH1-69 usage: a distinct CLL subgroup with more indolent behavior?具有突变型IgVH1-69使用情况的慢性淋巴细胞白血病：一种行为更惰性的独特慢性淋巴细胞白血病亚组？

Leuk Lymphoma. 2008 Apr;49(4):648-9. doi: 10.1080/10428190801959059.

The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study.轻链 IgLV3-21 定义了慢性淋巴细胞白血病的一个新的预后不良亚组：一项多中心研究的结果。

Clin Cancer Res. 2018 Oct 15;24(20):5048-5057. doi: 10.1158/1078-0432.CCR-18-0133. Epub 2018 Jun 26.

Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status.Fc 受体样 2（FCRL2）是低风险慢性淋巴细胞白血病的一种新型标志物，并根据 IGHV 突变状态优化预后评估。

Blood Cancer J. 2019 May 15;9(6):47. doi: 10.1038/s41408-019-0207-7.

Prognostic Factors for Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病的预后因素

Curr Hematol Malig Rep. 2016 Feb;11(1):37-42. doi: 10.1007/s11899-015-0294-x.

Double IGHV DNA gene rearrangements in CLL: influence of mixed-mutated and -unmutated rearrangements on outcomes in CLL.慢性淋巴细胞白血病中的双IGHV DNA基因重排：混合突变与未突变重排对慢性淋巴细胞白血病预后的影响

Blood Cancer J. 2016 Jul 1;6(7):e440. doi: 10.1038/bcj.2016.49.

本文引用的文献

All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia.全慢性淋巴细胞白血病：一种用于慢性淋巴细胞白血病分子特征分析的基于捕获的新一代测序面板。

Hemasphere. 2023 Sep 21;7(10):e962. doi: 10.1097/HS9.0000000000000962. eCollection 2023 Oct.

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.IGLV3-21R110突变对未经治疗的慢性淋巴细胞白血病患者具有预后价值。

Blood Adv. 2023 Dec 12;7(23):7384-7391. doi: 10.1182/bloodadvances.2023010132.

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL.慢性淋巴细胞白血病中的免疫球蛋白基因序列分析：ERIC（慢性淋巴细胞白血病欧洲研究倡议）的 2022 年更新建议。

Leukemia. 2022 Aug;36(8):1961-1968. doi: 10.1038/s41375-022-01604-2. Epub 2022 May 25.

Blood. 2021 May 27;137(21):2935-2946. doi: 10.1182/blood.2020008311.

Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).慢性淋巴细胞白血病常见定型亚群对预后的影响：德国 CLL 研究组（GCLLSG）前瞻性临床试验内的分析。

Haematologica. 2020 Nov 1;105(11):2598-2607. doi: 10.3324/haematol.2019.231027.

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.刻板亚群之间的高阶连接：对 CLL 中改善患者分类的影响。

Blood. 2021 Mar 11;137(10):1365-1376. doi: 10.1182/blood.2020007039.

Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4320-4327. doi: 10.1073/pnas.1913810117. Epub 2020 Feb 11.

Clin Cancer Res. 2018 Oct 15;24(20):5048-5057. doi: 10.1158/1078-0432.CCR-18-0133. Epub 2018 Jun 26.

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.iwCLL 指南：用于 CLL 的诊断、治疗指征、疗效评估和支持性管理。

Blood. 2018 Jun 21;131(25):2745-2760. doi: 10.1182/blood-2017-09-806398. Epub 2018 Mar 14.

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.利用VH3-21基因的慢性淋巴细胞白血病表现出高度受限的Vlambda2-14基因使用和同源互补决定区3（CDR3）：这意味着识别共同的抗原表位。

Blood. 2003 Jun 15;101(12):4952-7. doi: 10.1182/blood-2002-11-3485. Epub 2003 Feb 13.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验